by David Wallace
Patients are Asking - Episode 2 of 3
In this interview with MPN expert, Dr. Angela Fleischman, we discuss the latest treatments for myelofibrosis (MF) and when a clinical trial should be considered.
Research has linked MPNs to a pre-disposition to autoimmune disorders such as Lupus, Crohn's disease and Psoriasis just to name a few. Keep watching to learn why this occurs.
Discover the latest on a clinical trial for N-Acetylcysteine (NAC) in patients with myeloproliferative neoplasms. We have published research on NAC and remain hopeful on its usefulness.
Featuring: Dr. Angela Fleischman
Thank you to our Sponsors
